KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 192 filers reported holding KITE PHARMA INC in Q4 2016. The put-call ratio across all filers is 2.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $51,716,000 | -12.6% | 1,153,353 | +8.9% | 0.01% | -11.1% |
| Q3 2016 | $59,156,000 | +16.2% | 1,058,999 | +4.0% | 0.01% | +12.5% |
| Q2 2016 | $50,894,000 | +15.8% | 1,017,884 | +6.4% | 0.01% | +14.3% |
| Q1 2016 | $43,931,000 | -20.2% | 956,903 | +7.0% | 0.01% | -22.2% |
| Q4 2015 | $55,084,000 | +24.0% | 893,935 | +12.1% | 0.01% | +12.5% |
| Q3 2015 | $44,405,000 | +63.5% | 797,499 | +79.0% | 0.01% | +100.0% |
| Q2 2015 | $27,158,000 | +53.2% | 445,426 | +44.9% | 0.00% | +33.3% |
| Q1 2015 | $17,726,000 | +30.5% | 307,321 | +30.5% | 0.00% | +50.0% |
| Q4 2014 | $13,581,000 | +564.8% | 235,498 | +228.6% | 0.00% | – |
| Q3 2014 | $2,043,000 | – | 71,674 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |